[Dental Archive] HASSBIO and Yonsei University College of Dentistry Research Team "Accelerating Domestication of Hybrid Blocks and Non-Erosive Cement(RMGIC)!"
  • Date : 2023.07.10



HASSBIO and Yonsei University College of Dentistry Research Team "Accelerating Domestication of Hybrid Blocks and Non-Erosive Cement(RMGIC)!"

The joint project conducted by HASSBIO (CEO: Kim Yong-su) and Yonsei University College of Dentistry (Dean: Lee Ki-joon) research team (professor Choi Sung-hwan, Kwon Jae-seong, and Kim Do-hyun) has been selected for the "National R&D Project for Convergence Medical Devices" organized by the Korea Medical Device Development Foundation (KMDF) under the category of "Follow-up Support for Excellent Results and Early Outcome Achievement-oriented National Projects."

HASSBIO recently announced, "Yonsei University College of Dentistry's professors Choi Sung-hwan, Kwon Jae-seong, and Kim Do-hyun's team has received approximately 2.1 billion KRW in government support from KMDF." They further stated, "In the future, HASSBIO and Yonsei University's joint research team plan to focus on the research, development, and commercialization of 'Dental CAD/CAM Hybrid Blocks and Resin-Modified Glass Ionomer Cement (RMGIC)' with the goal of domestication."

Additionally, they mentioned, "Separately, we will pursue certification to apply the bipolar network modifier (mZM) developed by Yonsei University's professors Choi Sung-hwan and Kwon Jae-seong to our products."


The joint research team expects that this project will serve as a good example of collaboration between companies and research institutions, leading to the commercialization of dental biomaterials and reducing dependence on foreign medical devices in the domestic industry. Professor Choi Sung-hwan stated, "Based on our technology for inhibiting biofilm formation, we will actively pursue product development in collaboration with Hass, aiming to contribute to public health and reduce overseas dependence by developing excellent domestic products."

Sungmin Kim, Director of AIB center stated, "Developing technology for inhibiting biofilm formation in collaboration with outstanding researchers aligns with the company's mission as a 'Human-Aid System Supplier.'" He added, "We clearly recognize the national significance of this project and will do our best for its success."



Source: Dental Archive


Newsletter

Subscribe to our newsletter to receive new updates.

+ Subscribe